ProstaVive highlights eight ingredients spanning prostate wellness, urinary function, stress adaptation, male hormonal measures and vitality: boron, Tongkat Ali, ashwagandha, fenugreek, Panax ginseng, maca root, artichoke extract and nettle root.
Highlighted formula
The eight highlighted ingredients are boron, Tongkat Ali, ashwagandha, fenugreek, Panax ginseng, maca root, artichoke extract and nettle root.
Boron participates in mineral and hormone-related physiology. A 2004 observational analysis reported an association between higher dietary boron intake and lower prostate-cancer prevalence, but its cross-sectional design cannot prove prevention or treatment.
A 2022 meta-analysis of clinical trials reported a possible increase in total testosterone. The authors also called for more research, and the effect cannot be assumed for every extract or every man.
Ashwagandha trials have examined stress, vitality, testosterone and sexual well-being. Findings differ by population, standardised extract and dose, so they provide ingredient context rather than product-level proof.
Fenugreek extracts have been studied for libido and hormone measures. Some trials report changes, while newer work shows that between-group differences can be limited or dose-dependent.
A Cochrane review found low-certainty evidence and a small average effect for erectile-function measures. Ginseng should not be presented as a replacement for investigation or established treatment.
A systematic review identified limited evidence for sexual-function outcomes, with small trials and methodological limitations. Maca’s inclusion is better understood as a male-vitality component than a proven prostate treatment.
Artichoke extract contains polyphenols studied in metabolic and antioxidant contexts. It does not have a strong direct clinical evidence base for treating prostate symptoms.
Nettle root has the most directly relevant urinary research among the highlighted botanicals. A randomised trial examined 450 mg daily in men with benign prostatic enlargement over 12 weeks.
The public product information reviewed does not support publishing verified individual amounts for the highlighted ingredients.
This matters because herbal evidence is dose-, extract- and strain-specific. A study using a standardised extract cannot confirm that a different preparation at an unknown amount will produce the same result.
Evidence quality
Tongkat Ali, ashwagandha, fenugreek, ginseng, maca and nettle root have human research, but the relevance and quality differ substantially.
Nettle-root research includes men with benign prostatic enlargement and urinary symptoms, making it more directly relevant than general vitality studies.
Tongkat Ali, ashwagandha and fenugreek have been studied for male hormonal measures, fatigue, stress or sexual well-being.
Maca and ginseng systematic reviews report limited or low-certainty evidence and should be interpreted conservatively.
The boron study reported an association, but observational data cannot establish that taking boron changes disease risk.
Artichoke extract contributes broader metabolic and antioxidant context rather than strong prostate-specific clinical evidence.
Research on individual ingredients does not establish the effectiveness, safety or optimal duration of the complete ProstaVive blend.
Yes. Botanical ingredients may affect blood pressure, blood sugar, sedation, thyroid function, liver enzymes, hormones or anticoagulant therapy.
Men taking prescription medication or preparing for surgery or diagnostic testing should review the full label with a healthcare professional.
The ProstaVive review scores the formula’s breadth, evidence quality, transparency, value and practical use.
Read the ProstaVive ReviewIngredient questions
Yes. Nettle root is one of the eight ingredients highlighted by the current product information.
Saw palmetto is not included in the eight highlighted ingredients used for this page. Check the current product label through the purchase link for the complete formula.
Yes. Tongkat Ali, also known as Eurycoma longifolia, is highlighted in the formula.
No finished-product clinical trial was identified in the sources used for this guide.
That depends on the medication and medical history. A pharmacist or doctor should assess possible interactions.